Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
136.50
+0.50 (0.37%)
At close: Feb 13, 2026

HKG:2637 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
136.08117.4568.98
Depreciation & Amortization
4.983.892.81
Loss (Gain) From Sale of Assets
-0.030.02
Loss (Gain) From Sale of Investments
-1.14-0.14
Stock-Based Compensation
00.010.03
Provision & Write-off of Bad Debts
0.130.67-0.06
Other Operating Activities
15.423.2429.24
Change in Accounts Receivable
-22.78-25.475.62
Change in Inventory
-10.413.4-5.54
Change in Accounts Payable
33.925.61-13.2
Change in Unearned Revenue
7.78-1.72-2.73
Operating Cash Flow
163.94147.1185.31
Operating Cash Flow Growth
11.45%72.44%-
Capital Expenditures
-178.56-58.71-3.07
Sale (Purchase) of Real Estate
--0.78-28.63
Investment in Securities
-244.13100.42-22.04
Other Investing Activities
43.98-53.69-0.02
Investing Cash Flow
-378.72-12.77-53.76
Long-Term Debt Issued
17.835.57-
Long-Term Debt Repaid
-4.83-46.91-9.84
Net Debt Issued (Repaid)
13-41.34-9.84
Issuance of Common Stock
--157.6
Other Financing Activities
-14.27-10.15-14.63
Financing Cash Flow
-1.27-51.49133.13
Net Cash Flow
-216.0482.85164.68
Free Cash Flow
-14.6288.3982.24
Free Cash Flow Growth
-7.47%-
Free Cash Flow Margin
-3.13%27.92%38.71%
Free Cash Flow Per Share
-0.221.311.28
Cash Interest Paid
13.4310.1514.63
Cash Income Tax Paid
4.280.01-
Levered Free Cash Flow
-57.359.52-
Unlevered Free Cash Flow
-52.7964.36-
Change in Working Capital
8.51.81-15.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.